No,구분,개별,평가의뢰일,평가의뢰기관,재평가,평가의뢰종목,법인번호,평가종류,회차,민감도,주기,기준일,평가값송부일,보고서송부일,민감도송부일,평가담당자,공수,전기평가,RM,결과보고서송부,등록월,등록그룹,담당자,연락처,Mail,평가목적,종목등록일
6674,-,개별종목,2024-07-04,한성크린텍,재평가,"한성크린텍(구,이엔코퍼레이션)",1313110026091 ,D02,30,-,미정,2024-06-30,2024-07-12,2024-07-22,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,김수정과장,02-6371-3923,sujeong@hscleantech.com,회계반영,0
6675,-,개별종목,2024-07-04,한성크린텍,재평가,"한성크린텍(구,이엔코퍼레이션)",1313110026091 ,D02,31,-,미정,2024-06-30,2024-07-12,2024-07-22,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,김수정과장,02-6371-3923,sujeong@hscleantech.com,회계반영,0
6676,-,개별종목,2024-07-04,한성크린텍,재평가,"한성크린텍(구,이엔코퍼레이션)",1313110026091 ,D02,32,-,미정,2024-06-04,2024-07-12,2024-07-22,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,김수정과장,02-6371-3923,sujeong@hscleantech.com,회계반영,0
6677,-,개별종목,2024-07-04,한성크린텍,재평가,"한성크린텍(구,이엔코퍼레이션)",1313110026091 ,D02,33,-,미정,2024-06-30,2024-07-12,2024-07-22,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,김수정과장,02-6371-3923,sujeong@hscleantech.com,회계반영,0
6733,-,개별종목,매월,"IBK투자증권(PI부)(구,투자금융팀)",신규,호텔신라,1101110145519 ,D01,75,-,분기,2024-07-31,2024-08-01,보고서제공X,-,상장, - ,상장,서경덕,서경덕,202407,[Y]금융기관,박태우선임,02-6915-5390,sliding_had@ibks.com,회계반영,0
6734,-,개별종목,매월,"IBK투자증권(PI부)(구,투자금융팀)",재평가,호텔신라,1101110145519 ,D01,75,-,분기,2024-08-31,2024-09-02,보고서제공X,-,상장, - ,상장,서경덕,서경덕,202408,[Y]금융기관,박태우선임,02-6915-5390,sliding_had@ibks.com,회계반영,0
6735,-,개별종목,매월,"IBK투자증권(PI부)(구,투자금융팀)",재평가,호텔신라,1101110145519 ,D01,75,-,분기,2024-09-30,2024-10-01,보고서제공X,-,상장, - ,상장,서경덕,서경덕,202409,[Y]금융기관,박태우선임,02-6915-5390,sliding_had@ibks.com,회계반영,0
6736,코넥스종가사용 -> 공수X,개별종목,2024-07-09,루트락,재평가,루트락,1211110269473 ,D02,3,-,반기,2024-06-30,2024-07-26,2024-08-02,-,백형진, - ,백형진,-,-,202406,[X]일반기업,이진희매니저,02-6941-4314,jini@rootloc.com,회계반영,0
6737,코넥스종가사용 -> 공수X,개별종목,2024-07-09,루트락,재평가,루트락,1211110269473 ,D02,33,-,반기,2024-06-30,2024-07-26,2024-08-02,-,백형진, - ,백형진,-,-,202406,[X]일반기업,이진희매니저,02-6941-4314,jini@rootloc.com,회계반영,0
6738,-,개별종목,2024-07-09,동국제약,재평가,동국제약,1101110094477 ,D06,0,-,분기 ,2024-06-30,2024-07-12,2024-07-19,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,오규호팀장,"02-2191-9848, 010-3885-0409",okh@dkpharm.co.kr ,회계반영,0
6739,-,개별종목,2024-07-09,전진바이오팜,재평가,전진바이오팜,1701110273433 ,D02,8,-,분기,2024-06-05,2024-07-17,2024-07-24,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,장혜경팀장,053-593-7192,"hkjang@jjbio.co.kr

",회계반영,0
6740,-,개별종목,2024-07-09,전진바이오팜,재평가,전진바이오팜,1701110273433 ,D02,81,-,분기,2024-06-07,2024-07-17,2024-07-24,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,장혜경팀장,053-593-7192,"hkjang@jjbio.co.kr

",회계반영,0
6741,-,개별종목,2024-07-09,전진바이오팜,재평가,전진바이오팜,1701110273433 ,D02,82,-,분기,2024-06-30,2024-07-17,2024-07-24,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,장혜경팀장,053-593-7192,"hkjang@jjbio.co.kr

",회계반영,0
6742,-,개별종목,2024-07-09,한솔테크닉스,재평가,한솔테크닉스,1101110004682 ,D06,0,-,미정,2024-07-18,2024-07-19,2024-07-26,-,상장, - ,상장,메자닌평가팀,메자닌평가팀,202406,[W]상장기업,조민우책임,"043-530-8155, 010-6575-2120",jominwoo@hansol.com,회계반영,0
